UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory Note
Item 5.07 Submission of Matters to a Vote of Security Holders.
The Company held its 2022 Annual Meeting on October 12, 2022. A total of 31,486,533 shares of the Company’s common stock were present in person or represented by proxy at the 2022 Annual Meeting, representing approximately 79.89% of the Company’s common stock entitled to vote as of the September 6, 2022 record date (the “Record Date”). The following is a brief description of each matter voted upon at the 2022 Annual Meeting and the number of votes cast for, withheld or cast against, the number of abstentions and the number of broker non-votes with respect to each matter, as applicable.
1. The election of the director nominee to serve as a Class II director for a three-year term to expire at the 2025 annual meeting of stockholders or until his successor is duly elected. The following Class II director was elected by the votes indicated.
|
For |
|
Withheld |
|
Broker Non-Votes |
A. Brooke Seawell |
23,204,323 |
|
2,004,566 |
|
6,277,644 |
2. The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. The selection was ratified by the votes indicated.
For |
|
Against |
|
Abstain |
30,759,064 |
|
514,798 |
|
212,671 |
3. The approval, on a non-binding, advisory basis, of the frequency of future advisory votes on the compensation of the Company’s NEOs. “One year” was approved as the frequency of future advisory votes on NEO compensation by the votes indicated.
One Year |
|
Two Years |
|
Three Years |
|
Abstain |
|
Broker Non-Votes |
24,136,540 |
|
176,725 |
|
614,875 |
|
280,749 |
|
6,277,644 |
4. The adoption of an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s common stock, at a ratio in the range of 1-for-5 to 1-for-50, such ratio to be determined by the Board of Directors and included in a public announcement. The amendment was adopted as the number of votes “FOR” represented a majority of the shares of our common stock outstanding as of the Record Date.
For |
|
Against |
|
Abstain |
29,680,740 |
|
1,690,552 |
|
115,241 |
5. The adoption of an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock of the Company from 300,000,000 to 450,000,000. The amendment was adopted as the number of votes “FOR” represented a majority of the shares of our common stock outstanding as of the Record Date.
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
23,723,677 |
|
1,444,064 |
|
41,148 |
|
6,277,644 |
6. The approval, for purposes of complying with Nasdaq Listing Rule 5635, of the issuance of shares of our common stock issuable upon conversion of the senior secured convertible notes issued, or issuable, pursuant to the Note Purchase Agreement, dated June 24, 2022, by and among the Company, PSC Echo, LP and Drivetrain Agency Services, LLC, as administrative agent and collateral agent. The issuance was approved by the votes indicated.
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
23,985,858 |
|
1,154,575 |
|
68,456 |
|
6,277,644 |
As previously reported in the Original Form 8-K, at the 2022 Annual Meeting, the Company conducted a non-binding advisory vote regarding the frequency of stockholder advisory approval of the compensation of the Company’s NEOs. Among the options presented to stockholders (every “One Year,” “Two Years” or “Three Years” or abstaining), the greatest number of votes were cast in favor of holding an advisory vote regarding the compensation of NEOs every year, which was also the frequency recommended to the stockholders by the Company’s Board of Directors. After considering the results of the stockholder advisory vote, the Company
decided that it would hold an advisory vote on the compensation of the Company’s NEOs every year, until the next required advisory vote on the frequency of such an advisory vote, which is expected to be held at the Company’s 2028 Annual Meeting of Stockholders.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
EARGO, INC. |
|
|
|
|
Date: |
June 16, 2023 |
By: |
/s/Adam Laponis |
|
|
|
Adam Laponis |